Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Nitipir

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Medicina (Kaunas, Lithuania)|November 27, 2025
Synchronous Versus Metachronous Multiple Malignant Tumors Involving the Digestive Tract: Predictors of Survival from a Single-Center Retrospective StudyAlexandru Vlad Oprita, Cornelia Nitipir, Eduard Achim, et al.
Chirurgia (Bucharest, Romania : 1990)|December 31, 2024
The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian CancerAna Maria Popa, Horia Teodor Cotan, Cristian I Iaciu, et al.
Chirurgia (Bucharest, Romania : 1990)|July 22, 2023
Systemic Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Colon CancerCristian Ion Iaciu, Radu Andrei Emilescu, Horia-Teodor Cotan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trialAlexandru C Grigorescu, Ioana N Draghici, Cornelia Nitipir, et al.
Chirurgia (Bucharest, Romania : 1990)|May 8, 2019
Watch and Wait Strategy for Rectal Cancer: 15 Years After the First Published Study. Are We any Closer to the Non-operative Management of Rectal Cancer?Adrian Tulin, Cornelia Nitipir, Iulian Slavu, et al.
Cureus|October 13, 2022
Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the LiteratureAndreea Parosanu, Cristina Orlov Slavu, Cristina Pirlog, et al.
International Journal of Molecular Sciences|April 17, 2025
Impact of Patient Profile on CDK4/6 Inhibitor Therapy Outcomes: A Real-World Data AnalysisIoana-Miruna Stanciu, Maria-Cristina Orlov-Slavu, Andreea-Ioana Parosanu, et al.
American Journal of Therapeutics|May 8, 2025
Current Knowledge and Implementation of Therapeutic Strategies in Cardio-Oncology: A National Physician-Based SurveyAndreea Cristina Ivanescu, Cornelia Nitipir, Horia Bumbea, et al.
Cureus|May 27, 2024
Gustave Roussy Immune Score (GRIm-Score) as a Prognostic and Predictive Score in Metastatic Colorectal CancerHoria Cotan, Cristian Iaciu, Emilescu Radu, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive BiomarkersAndreea Ioana Parosanu, Catalin Baston, Ioana Miruna Stanciu, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Medicina (Kaunas, Lithuania)|November 27, 2025
Synchronous Versus Metachronous Multiple Malignant Tumors Involving the Digestive Tract: Predictors of Survival from a Single-Center Retrospective StudyAlexandru Vlad Oprita, Cornelia Nitipir, Eduard Achim, et al.
Chirurgia (Bucharest, Romania : 1990)|December 31, 2024
The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian CancerAna Maria Popa, Horia Teodor Cotan, Cristian I Iaciu, et al.
Chirurgia (Bucharest, Romania : 1990)|July 22, 2023
Systemic Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Colon CancerCristian Ion Iaciu, Radu Andrei Emilescu, Horia-Teodor Cotan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trialAlexandru C Grigorescu, Ioana N Draghici, Cornelia Nitipir, et al.
Chirurgia (Bucharest, Romania : 1990)|May 8, 2019
Watch and Wait Strategy for Rectal Cancer: 15 Years After the First Published Study. Are We any Closer to the Non-operative Management of Rectal Cancer?Adrian Tulin, Cornelia Nitipir, Iulian Slavu, et al.
Cureus|October 13, 2022
Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the LiteratureAndreea Parosanu, Cristina Orlov Slavu, Cristina Pirlog, et al.
International Journal of Molecular Sciences|April 17, 2025
Impact of Patient Profile on CDK4/6 Inhibitor Therapy Outcomes: A Real-World Data AnalysisIoana-Miruna Stanciu, Maria-Cristina Orlov-Slavu, Andreea-Ioana Parosanu, et al.
American Journal of Therapeutics|May 8, 2025
Current Knowledge and Implementation of Therapeutic Strategies in Cardio-Oncology: A National Physician-Based SurveyAndreea Cristina Ivanescu, Cornelia Nitipir, Horia Bumbea, et al.
Cureus|May 27, 2024
Gustave Roussy Immune Score (GRIm-Score) as a Prognostic and Predictive Score in Metastatic Colorectal CancerHoria Cotan, Cristian Iaciu, Emilescu Radu, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive BiomarkersAndreea Ioana Parosanu, Catalin Baston, Ioana Miruna Stanciu, et al.
Pageof 6